Design Therapeutics (DSGN) Stock Price
Design Therapeutics Price
For Design Therapeutics, the net margin of -3,663,716.8% is down versus -245.4% a few years ago. The consensus 12-month price target for Design Therapeutics is 20.50 USD, about 76.4% above where the stock trades today. Of 13 analysts, 12 rate the stock a buy — an overall Buy consensus.
Design Therapeutics stock price
Design Therapeutics business model & stock analysis
Frequently asked questions about Design Therapeutics
Analysts currently set an average price target of 20.50 USD for the Design Therapeutics stock (median: 20.50 USD), implying +76.4 % versus the latest price. The consensus is based on 13 analyst ratings.
13 analysts currently rate the Design Therapeutics stock: 12 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Design Therapeutics to generate revenue of 117.33 M USD and earnings per share of -1.31 USD.
Converted at the current exchange rate, the Design Therapeutics share trades at 10.37 EUR (11.62 USD).
The Design Therapeutics share (DSGN) is listed on 1 stock exchanges, including: NASDAQ (DSGN).
The expected revenue of Design Therapeutics is 117.33 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Design Therapeutics is -75.00 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Design Therapeutics is currently -8.88. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Design Therapeutics stock.
The price-to-sales ratio (P/S) of Design Therapeutics is currently 5.68. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Design Therapeutics stock.
The Eulerpool Quality Score for Design Therapeutics is 2/10.
The ISIN of Design Therapeutics is US25056L1035. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Design Therapeutics is DSGN. The ticker symbol is used to trade Design Therapeutics shares on the stock exchange.
Design Therapeutics stock
Design Therapeutics Peer Group
Design Therapeutics Ticker
Design Therapeutics FIGI
All fundamentals and in-depth analysis of Design Therapeutics
Our stock analysis for Design Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Design Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.